ERT - CROss Alliance™

eResearchTechnology Inc. (ERT) and CROss Alliance™ announce to have in place a Joint Marketing Agreement, to mutually promote the activities of both organizations.


After a successful collaboration of several years in QTc prolongation studies, CROss Alliance and ERT have developed a mutually successful and meaningful working relationship. CROss Alliance has selected ERT as a preferred cardiac safety provider for all trials to be performed at the CROss Research Phase I unit in Switzerland and in support of all CROss trials around Europe. ERT has included CROss research Phase I unit among their recommended Clinical Phase I units in Europe.

A broad range of joint marketing activities will be performed through the year, including joint client visits, preparation of promotion documentation and joint attendance at Congresses. Based on the expertise and reliability of CROss Alliance and ERT, this agreement is certain to provide continued high quality services to our clients.

To learn more about ERT services visit: